Related references
Note: Only part of the references are listed.Involvement of Histone H3 Lysine 9 (H3K9) Methyltransferase G9a in the Maintenance of HIV-1 Latency and Its Reactivation by BIX01294
Kenichi Imai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Combinatorial Latency Reactivation for HIV-1 Subtypes and Variants
John C. Burnett et al.
JOURNAL OF VIROLOGY (2010)
Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+Cell Infection
Nancie M. Archin et al.
PLOS ONE (2010)
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Nancie M. Archin et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Xavier Contreras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Reactivation of Latent HIV-1 Infection by the Periodontopathic Bacterium Porphyromonas gingivalis Involves Histone Modification
Kenichi Imai et al.
JOURNAL OF IMMUNOLOGY (2009)
Sp1 Phosphorylation and Its Regulation of Gene Transcription
Nicole Y. Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Control of Stochastic Gene Expression by Host Factors at the HIV Promoter
John C. Burnett et al.
PLOS PATHOGENS (2009)
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
Nancy M. Archin et al.
AIDS (2008)
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir
Nathalie Sagot-Lerolle et al.
AIDS (2008)
Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4+ T cells
Shailesh K. Choudhary et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells
T. Sanda et al.
LEUKEMIA (2007)
c-Myc and sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter
Guochun Jiang et al.
JOURNAL OF VIROLOGY (2007)
Stability of the latent reservoir for HIV-1 in patients receiving valproic acid
Janet D. Siliciano et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing
Celine Marban et al.
EMBO JOURNAL (2007)
Transcriptional repression of human immunodeficiency virus type 1 by AP-4
K Imai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Transcription factors Ets2 and Sp1 act synergistically with histone acetyltransferase p300 in activating human interleukin-12 p40 promoter
HJ Sun et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2006)
Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IκB kinase inhibitor
AFB Victoriano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
SA Williams et al.
EMBO JOURNAL (2006)
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
G Lehrman et al.
LANCET (2005)
Novel inhibitors of human histone deacetylases: Design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SARA-based non-hydroxamates
T Suzuki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells
C Marban et al.
NUCLEIC ACIDS RESEARCH (2005)
Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs:: implications for the development of therapeutic strategies
D Demonté et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Ceramide, a target for antiretroviral therapy
CM Finnegan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter
M Lusic et al.
EMBO JOURNAL (2003)
Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-κB and inhibitors of deacetylases:: Potential perspectives for the development of therapeutic strategies
V Quivy et al.
JOURNAL OF VIROLOGY (2002)
RelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-κB and Sp1 actions
N Takada et al.
JOURNAL OF VIROLOGY (2002)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat
GC He et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1
JJ Coull et al.
JOURNAL OF VIROLOGY (2000)
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
TW Chun et al.
NATURE MEDICINE (2000)
Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding
T Suzuki et al.
GENES TO CELLS (2000)
Share Paper
